Introduction {#s0005}
============

Initially known as the non-A, non-B hepatitis (NANBH) virus ([@bib1]), the hepatitis C virus (HCV), which was identified in 1989 ([@bib10], [@bib25]), is a single-stranded positive-sense RNA virus ([@bib11]) classified as a member within the *Hepacivirus* genus in the *Flaviviridae* family ([@bib14], [@bib36]). With high divergence in sequence due to the error-prone nature of the viral RNA-dependent RNA polymerase, HCV is classified into 7 phylogenetic clades designated from genotype 1 through 7, with more than 30% divergence based on nucleotide sequences and over 70 subtypes within an individual genotype ([@bib51], [@bib52]). Chronic HCV infection is estimated to affect about 170 million people worldwide or \~3% of the world's population ([@bib31]). In addition, there are 3 to 4 million new yearly infected cases coupled with 350,000 patients dying from HCV-related diseases ([@bib49], [@bib62]). Despite the fact that HCV was identified over two decades ago, there is still no therapeutic vaccine for HCV infection and treatment regimen for chronic infections are limited with various serious side effects as well as high treatment cost ([@bib15], [@bib24]). Thus, identification and discovery of new, innovative, and effective treatment is highly desirable in order to curb the spread of HCV.

HCV has a 9.6 kb genome size with an open reading frame (ORF) flanked by two regulatory un-translated regions (UTR), the 5′UTR and 3′UTR, respectively ([@bib4]). The ORF is translated into a precursor polyprotein of approximately 3000 residues which is then co- and post-translationally processed by viral and cellular proteases into at least three structural proteins (core, E1, and E2), a small ion channel protein (p7), and six non-structural proteins (NS2, NS3, NS4A, NS4B, NS5A, and NS5B) ([@bib34], [@bib36]).

Although ample studies suggest a strong tie between chronic HCV infection and liver damage, the mechanisms involved are still not well established. A combination of viral cytopathic effects (CPE) and host immune responses are believed to contribute to the liver injury observed in HCV infection ([@bib21], [@bib45]). While HCV is not a cytolytic virus, studies have demonstrated that hepatocyte apoptosis plays a major part in the host anti-viral defense mechanism against HCV as it prevents viral replication as well as aids in the elimination of virus-infected hepatocytes ([@bib33]). Similarly, a number of recent studies using the HCV cell culture (HCVcc) system ([@bib35]) have shown that HCV can have direct CPE and induce cell death in the form of apoptosis in hepatocytes ([@bib13], [@bib39], [@bib42], [@bib61], [@bib63]). It is believed that HCV modulates host apoptosis by interacting with a couple of host factors. Ectopic expression of the individual viral proteins in cell culture as well as using the subgenomic replicon system, have shed more light on the contributions of the individual viral genes to host apoptosis (see review ([@bib3])). For instance, using a NS3-5B subgenomic replicon, [@bib30] showed that the HCV non-structural proteins are key modulators which sensitize human hepatoma cells to TRAIL-induced apoptosis. Similarly, data from our laboratory have previously demonstrated that the HCV core protein is pro-apoptotic and a novel BH3-only viral homologue ([@bib42]) while more recent data demonstrated that the small ion channel protein, p7, induces apoptosis in Huh7.5 cells in a caspase-dependent manner involving both the extrinsic and intrinsic pathways ([@bib2]). As the various HCV-encoded proteins play a different role in modulating host apoptosis by interacting and interfering with different host factors and/or cellular events, understanding how this intricate host-viral interaction is regulated so as to prevent premature death of infected cells and to establish persistent infection would be essential in understanding the disease pathogenesis and for instituting an effective treatment regimen.

In this study, we sought to identify the host apoptosis-related factors that are differentially regulated during HCV infection and subsequently the viral factor(s) responsible for modulating the host death response. Using an apoptosis-specific PCR array, we successfully identified 9 apoptosis-related genes that were differentially expressed during HCV infection. Of the 9 genes, BIK, a pro-apoptotic BH3-only protein of the Bcl-2 family, was consistently up-regulated at both the transcriptional and translational level. Depletion of BIK using small interfering RNA (siRNA) did not affect the growth of Huh7.5 cells but significantly decreased HCV RNA replication as well as the viral release indicating the importance of BIK expression during HCV infection. In addition, by utilizing the lentivirus system, we showed that transduction of NS5B of genotype 2a (JFH1 strain) into Huh7.5 is sufficient to induce an up-regulation of BIK. Finally, using immunofluorescence and co-immunoprecipitation analyses, we showed the co-localization and interaction of BIK and NS5B in infected cells, respectively, suggesting that BIK may be recruited or interacting with the HCV replication complex via NS5B to assist in the viral replication and release.

Results {#s0010}
=======

Effects of HCV infection on apoptosis-related genes expression {#s0015}
--------------------------------------------------------------

To examine the effects of HCV infection on host apoptosis, the RT² Profiler PCR Array Human Apoptosis platform was used to screen 84 apoptosis-related genes following a 6-day course of infection of Huh7.5 cells with J6/JFH-1-P47 virus. Samples were collected from three time points for analysis (2, 4, and 6 d.p.i.). Four independent experiments were performed and the mean fold change of the mRNA levels as compared to mock was determined. Genes with ≥3 fold changes and *p\<*0.05 at the mRNA level in at least one of the time points were selected for further verification. Upon validation using TaqMan qPCR, 9 genes were identified from the data that showed consistent up- or down-regulation upon HCV infection ([Fig. S1](#s0150){ref-type="sec"}). Using TaqMan qPCR method, we obtained a similar trend, although in general, a higher fold change in transcript level for most of the differentially expressed genes, especially at the 6 d.p.i. time point was observed, indicating that the TaqMan qPCR is more sensitive compared to the SYBR green system ([Fig. S1](#s0150){ref-type="sec"}) ([@bib7]). Further validation using Western blot analysis indicated that BIK showed consistent up-regulation at the protein level in two of the three time points that were examined and thus was selected as the focus of this study. As shown in [Fig. 1](#f0005){ref-type="fig"}, a significant increase in the mRNA level of *Bik* was observed as early as 2 d.p.i. ([Fig. 1](#f0005){ref-type="fig"}A) while the increase in protein expression was not seen until 4 and 6 d.p.i. ([Fig. 1](#f0005){ref-type="fig"}B). Nevertheless, both qPCR and Western blot analysis supported the PCR array data where infection with HCV leads to up-regulation of BIK expression. The tissue culture adapted J6/JFH-1-P47 virus has accumulated several mutations to achieve high infectivity in tissue culture system ([@bib6]). To determine whether the up-regulation of BIK is applicable to the parental HCV strain, a similar 6-day infection course was repeated using the J6/JFH-1-P1 virus. As shown in Supplementary [Fig. 2](#s0150){ref-type="sec"}, the level of BIK was also increased at both the mRNA and protein levels albeit to a lesser degree than in the P47-infected cells, with the most significant difference observed during 6 d.p.i. ([Fig. S2](#s0150){ref-type="sec"}). As the parental P1 virus is not tissue culture adapted and does not exert a similar level of CPE in host cell as the P47 virus, this result is as expected ([@bib13]). Thus, infection of Huh7.5 cells with HCV induces up-regulation of BIK independent of the mutations from the tissue culture adaptations in the J6/JFH-1-P47 virus.Fig. 1Real-time qPCR and Western blot validation of the PCR array data, performed for the expression of BIK following HCV infection. (A) Total RNA from HCV J6/JFH-1-P47-infected or mock-infected Huh7.5 cells harvested at 2, 4, and 6 d.p.i were used to assess mRNA levels by TaqMan qPCR using specific primers to *Bik* and normalized to endogenous GAPDH. The TaqMan qPCR data (gray bars) shown represent the mean±standard deviation of triplicate wells for four independent experiments. Fold-changes calculated for the PCR array data, which relied on single wells, hence, standard deviations are not displayed, are also indicated (white bars). *p*-Values were calculated using the Student's *T*-test with statistical significance between mock and infected marked by asterisks (^*⁎*^*p\<*0.05 and ^*⁎⁎*^*p\<*0.01). (B) Western blots were probed with human anti-BIK (top), anti-HCV core (middle), and anti-β-actin (bottom), which was used as a loading control. The Western blots shown represent one of three independent experiments.

siRNA knockdown of BIK does not affect Huh7.5 viability {#s0020}
-------------------------------------------------------

To study the functional role of BIK in HCV infection, depletion of BIK from Huh7.5 cells was performed using siRNA and the effect of such depletion on the host was examined by determining the cell viability or proliferation and apoptosis. To obtain sustained knockdown of BIK expression, 20 nM of siRNA targeting the human *Bik* (siBIK) was used to transfect Huh7.5 cells. The level of knockdown was assessed at 2, 4, 6, and 8 days post-transfection (d.p.t.). As shown in [Fig. 2](#f0010){ref-type="fig"}A, the endogenous BIK level was successfully depleted and sustained for up to day 8 post-transfection in the siBIK treated cells as compared to the control siRNA group (siCtrl) ([Fig. 2](#f0010){ref-type="fig"}A). Upon successful knockdown of BIK, cell viability assay was performed at the indicated time points between siBIK- and siCtrl-treated cells. As shown in [Fig. 2](#f0010){ref-type="fig"}B, the siBIK-mediated depletion of BIK in Huh7.5 cells did not adversely affect the cell viability across the four measured time points as both the siCtrl- and siBIK-treated cells had similar proliferation rates ([Fig. 2](#f0010){ref-type="fig"}B). These results suggested that depletion of endogenous BIK was attainable with 20 nM of siRNA for up to 8 days without affecting the viability or proliferation of the host cells.Fig. 2Sustained siRNA-mediated knockdown of BIK expression in Huh7.5 cells and effects on cell proliferation. (A) Huh7.5 cells transfected with 20 nM siBIK or siCtrl were harvested and analyzed by Western blot on 2, 4, 6, and 8 d.p.t using anti-human BIK antibodies, with the level of endogenous β-actin as control. The Western blots shown are a representative of three independent experiments. (B) Huh7.5 cells transfected with 20 nM siBIK or siCtrl were analyzed for cell proliferation/viability at 2, 4, 6, and 8 d.p.t. The percentage of cell viability on day 2 post-transfection was arbitrarily set at 100% and the percentages of the other samples relative to day 2 were then determined. Data from three independent experiments are shown with error bars representing the standard deviation.

BIK depletion reduced HCV-induced apoptosis {#s0025}
-------------------------------------------

Since BIK is a pro-apoptotic protein, we anticipated that in the absence of BIK cells would be less susceptible to HCV-induced apoptosis. To examine the cells' response to apoptosis stimulus from HCV infection, siBIK- or siCtrl-treated Huh7.5 cells were infected with HCV J6/JFH-1-P47 and cell viability assay was performed at 0, 2, 4, and 6 d.p.i. Immunoblot analysis revealed successful knockdown of BIK as well as a sustained HCV infection, as indicated by the HCV core protein level ( [Fig. 3](#f0015){ref-type="fig"}A). When the caspase-3/7 activity was measured, as an indication for the induction of apoptosis, HCV infected siBIK-treated cells showed a significantly lower caspase-3/7 activity at 4 and 6 d.p.i. as compared to the infected siCtrl-treated cells ([Fig. 3](#f0015){ref-type="fig"}B). To substantiate our observed attenuated apoptosis induction in siBIK-treated cells, TUNEL assay was performed to measure the nuclear DNA fragmentation in the infected cells as an indication for apoptosis ([@bib19]). Given that the caspase-3/7 activity assay was only significant on 4 and 6 d.p.i. ([Fig. 3](#f0015){ref-type="fig"}B), the TUNEL assay was performed for these two time points. As seen in Supplementary [Fig. 3](#s0150){ref-type="sec"}, there were more TUNEL positive cells in the HCV-infected siCtrl-treated cells than the HCV-infected siBIK-tread cells ([Fig. S3](#s0150){ref-type="sec"}), which further corroborated the caspase-3/7 ([Fig. 3](#f0015){ref-type="fig"}B) results that BIK-depleted Huh7.5 cells were less susceptible to HCV-induced apoptosis. Interestingly, when cell viability test was performed, depletion of BIK did not significantly affect the proliferation of Huh7.5 cells infected with HCV, as both HCV-infected siBIK- and siCtrl-treated cells had similar cell viability with proliferation rate progressively inhibited to the same extent by HCV infection when compared to their corresponding mock-infected cells ([Fig. 3](#f0015){ref-type="fig"}C). Even though the infected siBIK-treated cells had a reduced level of apoptosis ([Fig. 3](#f0015){ref-type="fig"}A, [Fig. S3](#s0150){ref-type="sec"}), their viability and proliferation remained unchanged as compared to the siCtrl-treated group.Fig. 3Apoptosis and proliferation of BIK-depleted Huh7.5 cells infected with HCV J6/JFH1-P47 virus. (A) HCV-infected siBIK or siCtrl transfected Huh7.5 cells were analyzed by Western blot at 0, 2, 4, and 6 d.p.i using anti-human BIK and anti-HCV core antibodies, with the level of endogenous β-actin as control. The Western blots shown are representative of three independent experiments. (B) HCV-infected siBIK or siCtrl transfected Huh7.5 cells were analyzed for Caspase-3/7 activation at 0, 2, 4, and 6 d.p.i. The readings were normalized to cell numbers as determined by the cell viability assay (see C). A representative figure is shown here with error bars representing the standard deviation. (C) HCV-infected siBIK or siCtrl transfected Huh7.5 cells were analyzed for cell viability/proliferation at 0, 2, 4, and 6 d.p.i. Readings were normalized to mock-infected samples, which were arbitrarily set at 100%. A representative data set is shown with error bars representing the standard deviation. *p*-Values were calculated using the Student's *T*-test with statistical significance shown by asterisks (^⁎^*p*\<0.05 and^⁎⁎^*p*\<0.01).

BIK depletion attenuated HCV replication and viral release {#s0030}
----------------------------------------------------------

To determine the functional significance of BIK on HCV, qPCR and IFA were used to examine the effect of BIK knockdown on HCV replication as well as viral release. Huh7.5 cells were transfected with either siCtrl or siBIK and on 2 d.p.t. HCV infection was performed at MOI of 2 for another 6 days. Data analysis from the qPCR assay showed a significant decrease in the level of HCV RNA replication in the infected siBIK-treated cells as compared to the infected siCtrl-treated cells ( [Fig. 4](#f0020){ref-type="fig"}A) on 4 and 6 d.p.i., indicating that BIK is essential for HCV replication in the host cells. A similar inhibitory effect, although not as drastic, was also observed at the protein level as shown in [Fig. 3](#f0015){ref-type="fig"}A. Reduction in the HCV core protein level in the siBIK-treated cells was observed especially on 6 d.p.i. (54% of the siCtrl sample) where the decrease in HCV RNA level was most significant ([Fig. 4](#f0020){ref-type="fig"}A). When the release of viral particles was examined using IFA, the number of infectious HCV particles released from the siBIK-treated cells was significantly lower on 4 and 6 d.p.i. when compared to the siCtrl-treated group ([Fig. 4](#f0020){ref-type="fig"}B). However, the reduction in viral release, although statistically significant, was not as drastic as compared to the decrease in viral RNA replication ([Fig. 4](#f0020){ref-type="fig"}A), as only less than 1log decrease was observed in the viral release results. This discrepancy has been observed by others as well where the amount of viral RNA does not always correlate with the number of infectious viral particles released into the supernatant ([@bib46]). Nonetheless, our results still support the fact that BIK depletion affects HCV RNA replication and the release of infectious HCV particles into the culture supernatant even though the effect on the latter was not that drastic.Fig. 4HCV replication and release of infectious viral particles into culture supernatant (B) HCV-infected siBIK or siCtrl transfected Huh7.5 cells were harvested at 2, 4, and 6 d.p.i, and analyzed for HCV replication using quantitative real-time PCR analysis and normalized to endogenous GAPDH. At least three independent experiments were performed and a representative data set is shown with error bars representing the standard deviation. *p*-Values were calculated from four independent sets of data using the Student's *T*-test with statistical significance shown by asterisks (^⁎⁎^*p*\<0.01). (C) Culture supernatant of HCV infected siBIK or siCtrl-treated Huh7.5 cells collected at 2, 4, and 6 d.p.i was used to re-infect naïve Huh7.5 cells. The virus infectivity/release was determined at 24 h post-infection using a HCV-infected patient's serum. A representative data set is shown here with error bars representing the standard deviation. *p*-Values were calculated using three independent data sets using the Student's *T*-test with statistical significance shown by asterisks (^⁎^*p*\<0.05).

NS5B induces an increase in BIK expression in Huh7.5 cells {#s0035}
----------------------------------------------------------

HCV encodes more than 10 viral proteins that have been reported to exhibit either pro- or anti-apoptotic, or both properties depending on the experimental design (see review ([@bib3])). Preliminary screening from our laboratory suggested that ectopic over-expression of NS5B via transient transfection in Huh7.5 cells led to increase BIK mRNA level ([Fig. S4](#s0150){ref-type="sec"}). In order to confirm this observation, lentivirus packaging the HCV NS5B gene was generated and used to transduce Huh7.5 cells. Samples collected at 72 and 96 h post-transduction showed that NS5B-transduced cells contained higher level of BIK at both the transcriptional ( [Fig. 5](#f0025){ref-type="fig"}A) and translational stages ([Fig. 5](#f0025){ref-type="fig"}B) for both time points as compared to the control vector-transduced sample. Samples from both the control vector- and NS5B-transduced cells were also probed with anti-GFP antibody to confirm the integration and transient expression of the EmGFP gene from the pLenti7.3 vector ([Fig. 5](#f0025){ref-type="fig"}B). This result indicated that HCV NS5B protein alone can induce BIK expression in Huh7.5 cells. To determine whether NS5B can induce apoptosis and thus indirectly induce BIK expression, the caspase-3/7 activity was examined in both the control vector- and NS5B-transduced samples at 4 different time points. As shown in supplementary [Fig. 5](#s0150){ref-type="sec"}, the caspase-3/7 activity was similar in both sets of samples across all four time points, suggesting that NS5B did not indirectly induce the expression of BIK by activating apoptosis ([Fig. S5](#s0150){ref-type="sec"}).Fig. 5HCV NS5B up-regulates BIK expression in HCV infection. (A) Total RNA from HCV NS5B or control vector transduced Huh7.5 cells were harvested at 72 and 96 h post-transduction and used to assess mRNA levels by TaqMan qPCR using specific primers to *Bik* and normalized to endogenous GAPDH. The data shown represent the mean±standard deviation of triplicate wells. At least three independent experiments were performed and a representative data set is shown here. *p*-Values were calculated using the Student's *T*-test with statistical significance between control vector or NS5B transduced cells marked by asterisks (^*⁎*^*p\<*0.05 and ^*⁎⁎*^*p\<*0.01). (B) Western blots were probed with human anti-BIK, anti-HCV NS5B, anti-GFP, and anti-β actin; GFP serves as control for transduction using pLenti7.3 vector. β-actin was used as a loading control. The Western blots shown represent one of three independent experiments.

Co-localization and interaction of BIK and NS5B during HCV infection {#s0040}
--------------------------------------------------------------------

Thus far, our results suggested that BIK is functionally significant for optimal replication of HCV in Huh7.5 cells ([Fig. 4](#f0020){ref-type="fig"}). The fact that NS5B alone is sufficient to up-regulate BIK expression in Huh7.5 cells ([Fig. 5](#f0025){ref-type="fig"}) led us to speculate whether NS5B interacts with BIK or both were localized within the same compartment to allow for an interaction. To ascertain this, immunofluorescence analysis were performed so as to determine the localization of BIK and NS5B during HCV infection. Confocal images revealed that both BIK and NS5B co-localized in the ER of HCV-infected Huh7.5 cells ( [Fig. 6](#f0030){ref-type="fig"}) confirming our speculation that NS5B maybe recruiting or interacting with BIK at the replication complex in the ER to assist in HCV replication. To confirm a possible interaction between NS5B and BIK, co-immunoprecipitation (Co-IP) analysis was performed using mock and P47-infected Huh7.5 cell lysate with NS5B antibody. As shown in [Fig. 7](#f0035){ref-type="fig"}A, NS5B protein is only present in the P47-infected cell lysate and the level of BIK was increased in the infected sample ([Fig. 7](#f0035){ref-type="fig"}A). Using anti-NS5B antibody, BIK was successfully precipitated from the P47-infected cell lysate while absent in the mock lysate ([Fig. 7](#f0035){ref-type="fig"}B). To rule out the possibility of BIK unspecifically binding to the protein A beads or the antibody, 1A9, a species matched non-related antibody against SARS spike protein ([@bib43]), was used as a negative control. Our results thus showed positive co-precipitation of BIK with NS5B antibody and not with the control antibody ([Fig. 7](#f0035){ref-type="fig"}B). Hence, both the immunofluorescence and Co-IP data confirmed that BIK interacts physically with NS5B and possibly the HCV replication complex.Fig. 6BIK and NS5B co-localize within the ER in HCV infected Huh7.5 cells. Immunofluorescence analysis was performed on HCV-infected Huh7.5 cells using antibodies against BIK, NS5B, and ER markers (calreticulin and calnexin). Nuclei were counterstained with DAPI (blue). Three independent experiments were performed with a representative set of images shown here.Fig. 7Co-immunoprecipitation (IP) of BIK with NS5B. Cell lysates from mock and P47-infected Huh7.5 were prepared and subjected to Co-IP using antibody against NS5B and a control antibody of the same species, anti- SARS spike protein. (A) Cell lysates and (B) Co-IP products were analyzed via Western blot and probed with antibodies against BIK. β actin was used as loading control.

Discussion {#s0045}
==========

The molecular characterization of the factors important in HCV infection and HCV-induced apoptosis is not only important in understanding the mechanisms and pathogenesis of the disease but also to provide new targets in the development of novel antiviral therapies. For HCV-induced apoptosis, both host and viral factors have been implicated, however, the molecular mechanisms and the specific factor(s) which perpetuate this process remains largely unknown. The Bcl-2 family members are the major molecular players in programmed cell death ([@bib16], [@bib23]), with some BH3-only proteins reported to play a role in HCV infection ([@bib53]). The BH3-only pro-apoptotic members, which are the allosteric regulators of the Bcl-2 family members, are known to bind strongly to the pro-survival members through their BH3 domains thereby antagonizing their pro-survival function ([@bib8]). HCV infection has been shown to activate apoptosis through the induction of cell-death related genes and caspase activation (see review ([@bib3])). Using gene profiling analysis, [@bib61] revealed that the induction of apoptosis-related genes was linked to the viral load and that this induction of apoptosis was in response to the cell cycle arrest caused by the HCV infection. Among the apoptosis-related genes identified was the Bcl-2 family BH3-only protein, NBK/BIK, the gene of interest in this study that was also identified in our PCR array analysis ([Fig. 1](#f0005){ref-type="fig"}). An elevation of BIK expression has been reported in a number of viral infections including HCV infection ([@bib9], [@bib56], [@bib61]). However, the functional significance and the molecular mechanisms leading to the up-regulation of BIK expression in HCV infection remain unexplored.

In this study, pathway focused PCR array analysis was first used to screen for apoptosis-related genes that are dysregulated during HCV infection. After validation using qPCR ([Fig. S1](#s0150){ref-type="sec"}) and Western blot analysis (data not shown), only the differential expression of BIK was found to be consistently up-regulated at both the transcriptional and translational levels ([Fig. 1](#f0005){ref-type="fig"}). Most importantly, we showed that the up-regulation of BIK in HCV J6/JFH-1-P47 infection is not a consequence of the mutations accumulated in this tissue culture adapted virus as induction of BIK expression was also observed in cells infected with the parental HCV J6/JFH-1-P1 virus ([Fig. S2](#s0150){ref-type="sec"}).

In order to decipher the role of BIK in HCV infection, depletion of BIK was performed using RNAi system. As BIK is a pro-apoptotic protein, in the absence of it, cells are expected to be less susceptible to apoptosis stimulus. As expected, the level of apoptosis induced in the form of caspase-3/7 activation and DNA fragmentation (TUNEL positive cells) was significantly higher in the HCV-infected control cells than in the HCV-infected BIK-depleted cells ([Fig. 3](#f0015){ref-type="fig"}B and [Fig. S3](#s0150){ref-type="sec"}). Our observation is in accordance with studies from other groups examining the effect of BIK knockdown and apoptosis, where BIK-depleted cells were more resistant to apoptosis induced by various agents ([@bib18], [@bib26], [@bib32], [@bib41], [@bib50], [@bib59]). In terms of viral induced apoptosis and BIK expression, our observation is in accordance with these studies.

When the effects of BIK depletion on the host cell following HCV infection was examined, no significant difference was observed in the cell viability between the infected BIK-depleted and the control cells, as the proliferation of both infected groups were inhibited to the same extent by HCV relative to the mock ([Fig. 3](#f0015){ref-type="fig"}C). A similar observation was made by [@bib58] where they reported that mouse embryonic fibroblasts (MEFs) deficient in a number of BH3-only proteins, including Bim, Bik, Bmf, BAD, Puma, Noxa or a combination of Bim and BAD (Bim/BAD DKO), died in response to Semliki Forest virus (SFV) infection in a similar manner as wild-type MEFs. This thus gives us quite an intriguing contrast because, while the loss of pro-apoptotic BIK protected against HCV-induced apoptosis, there was no significant effect on the cell viability upon HCV infection ([Fig. 3](#f0015){ref-type="fig"}B). A couple of reasons could account for this unusual dichotomy. First, it has been demonstrated that there is a diversion of cells to autophagic cell death when there is deficiency or block in apoptosis ([@bib48]). Thus, it is probable that the decrease in apoptosis in the HCV-infected BIK-depleted cells is compensated for by an increase in autophagic or other forms of cell death. Recent studies have identified that the Bcl-2 binding partner, Beclin-1 may serve as a link for the crosstalk between the apoptotic and autophagic signaling pathways (see review [@bib20]). [@bib47] showed that one way of regulating autophagy activation is by sequestering the key inducer of autophagy, Beclin-1, by the Bcl-2 family proteins. A more recent study reported that BCLAF1, a Bcl-2 interacting protein, induces autophagic cell death in myeloma cells by displacing Beclin-1 from Bcl-2 protein ([@bib29]). Our PCR array screening identified BCLAF1 as one of the genes that were up-regulated during HCV infection and was also validated by TaqMan qPCR ([Fig. S1](#s0150){ref-type="sec"}). In the absence of BIK, the increased BCLAF1 expression could in turn activate the autophagic cell death pathway which could possibly explain why the absence of BIK did not have an impact on cell viability ([Fig. 3](#f0015){ref-type="fig"}C) despite a significant decrease in apoptosis induction ([Fig. 3](#f0015){ref-type="fig"}B, [Fig. S3](#s0150){ref-type="sec"}). In addition, the functional redundancy within the BH3-only proteins ([@bib5], [@bib12], [@bib22], [@bib60]) could also be accountable for the lack of effect of BIK depletion on cell viability in HCV-infected cells.

Viral replication is generally affected by the ability of the virus to counteract pro-apoptotic signals induced by host cells, since premature cell death of infected cells would prevent the production of progeny virions. It is therefore expected that in the absence of pro-apoptotic BIK, viral replication will be enhanced. Interestingly, BIK-knockdown suppresses HCV RNA replication (40% to 50% cf. control) and production of HCV particles (ca. 65% cf. control), suggesting the possible role of BIK in HCV RNA replication ([Fig. 4](#f0020){ref-type="fig"}). In order to understand which step in the virus life-cycle that BIK could be involved in, the effects of individual viral proteins on the expression of BIK were determined. Our results show that the expression of NS5B alone is sufficient to increase *Bik* expression at both the mRNA and protein levels ([Fig. 5](#f0025){ref-type="fig"}). So what is the functional significance of BIK up-regulation during HCV infection? The HCV replication complex is in the endoplasmic reticulum (ER) ([@bib17]) where BIK is known to be localized ([@bib40]). Immunofluorescence analysis revealed that in HCV-infected Huh7.5 cells both BIK and NS5B are localized in the same compartment within the ER ([Fig. 6](#f0030){ref-type="fig"}). Further analysis using Co-IP showed a positive interaction between BIK and NS5B ([Fig. 7](#f0035){ref-type="fig"}B). This raises some further interesting questions as to whether NS5B is involved in the recruitment of BIK to the replication complex to assist in HCV replication. Interestingly, several critical interactions between cellular factors and the replication complex of HCV have been reported. For example, HCV NS5A has been shown to specifically interact with the host cell protein TBC1D20 (a Rab1 GTPase-activating protein), depletion of which severely impaired HCV replication and prevented the accumulation of viral RNA ([@bib54]). Similarly, the interaction of HCV NS4B with Rab5 (also a Rab GTPase) was demonstrated to be crucial for HCV replication ([@bib38], [@bib55]).

Taken together, our present results suggest that BIK is highly up-regulated during HCV infection and to a lesser extent, by NS5B alone. BIK-depleted Huh7.5 cells are protected against HCV-induced caspase-dependent apoptosis, but did not protect the cells against the inhibitory effects of HCV infection on cell viability. More importantly, the data suggest that BIK is essential for HCV RNA replication and viral release as knockdown of BIK significantly affected HCV viral replication and release. BIK is therefore an important host factor that plays a vital role in the host cells' response to HCV infection and may influence some aspects of the viral life cycle independent of its role in regulating apoptosis during infection. Lastly, both BIK and NS5B are shown to interact as well as co-localized in the same compartment within the ER where the HCV replication complex occurs. It is therefore conceivable to postulate that the interaction between BIK and NS5B in the replication complex is essential for HCV replication. Future work would be done to substantiate this hypothesis.

Materials and methods {#s0050}
=====================

Cell lines and reagents {#s0055}
-----------------------

Huh7.5 cells (subclone of the Huh-7 human hepatoma cell line; Apath, Brooklyn, NY) and 293FT cells (human embryonic kidney cell line with the temperature sensitive gene for SV40 T-antigen; Invitrogen, Karlsruhe, Germany) were grown in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (HyClone, Utah, USA), 0.1 mM nonessential amino acids, and antibiotics (10 units/ml penicillin and 10 μg/ml streptomycin) (Invitrogen). All cells were maintained in a 37 °C incubator with 5% CO~2~.

Viruses {#s0060}
-------

HCV J6/JFH-1-P47 virus ([@bib6]), which is a tissue culture adapted strain of the J6/JFH-1 chimeric virus that possesses enhanced infectivity, was used in majority of the experiments. The adapted virus was obtained by passaging J6/JFH-1-infected cells 47 times and contains 10 amino acid mutations (K78E, T396A, T416A, N534H, A712V, Y852H, W879R, F2281L, M2876L and T2925A) and a single nucleotide mutation in the 5′-UTR (U146A). For the generation of the parental J6/JFH-1-P1 virus (P1 virus), full-length viral RNA was in vitro transcribed using MEGAscript T7 kit (Ambion, Austin, TX) and electroporated into Huh7.5 cells as described ([@bib28]). Supernatant containing P1 virus was further concentrated 10-fold using Amicon Ultra-15 Centrifugal Filter Units with 100 kDa cut off (EMD Millipore Corporation, Billerica, MA) and stored at −80 °C.

Lentivirus used in the transduction assay was generated using the ViraPower HiPerform Lentiviral Expression Systems (Invitrogen) by cloning the full length NS5B amplified from the parental J6/JFH-1 plasmid into the pLenti7.3/V5-TOPO vector. pLenti7.3/V5-GW/lacZ provided in the kit was used as control vector for transduction. Lentivirus packaging the gene of interest or the control vector were generated in 293FT cells following the manufacturer's instruction.

Generation of anti-NS5B monoclonal antibody {#s0065}
-------------------------------------------

The cDNA encoding for the N-terminal fragment (residues 1 to 385) of NS5B of JFH-1 HCV was cloned into the pGEX-6P1 vector (GE Healthcare, Uppsala, Sweden). Glutathione S-transferease (GST)-fusion NS5B protein was then expressed in *Escherichia coli* BL21(DE3) (Novagen, EMD Chemicals, Inc., Madison, WI) and purified as previously described ([@bib57]). The GST-fusion protein was then used to immunize mice and generate hybridomas as previously described ([@bib44]). All mice were handled according to National Advisory Committee for Laboratory Animal Research (NACLAR) guidelines.

SDS-PAGE and immunobloting {#s0070}
--------------------------

Proteins were separated by SDS-PAGE and transferred to nitrocellulose or PVDF membranes using wet transfer. Following transfer, membranes were blocked in 5% (w/v) skimmed milk powder, 0.1% (v/v) Tween20 in Tris-Buffered Saline (TBS) (blocking buffer), and incubated with the appropriate primary and secondary antibodies. The primary antibodies used in this study include: homemade anti-HCV NS5B monoclonal, anti-β-actin monoclonal, anti-BIK (NBK) polyclonal (Santa Cruz Biotechnology, Santa Cruz, CA), anti-HCV core monoclonal (Pierce/Thermo scientific, Rockford, IL), and anti-GFP monoclonal (Roche, Indianapolis, IN) antibodies. Secondary antibodies used include: horseradish peroxidase (HRP)-conjugated goat anti-mouse and rabbit anti-goat antibodies (Pierce, Rockford, IL). Protein bands were visualized by enhanced chemiluminescence (ECL) according to the manufacturer's protocol.

HCV infection {#s0075}
-------------

Monolayers of Huh7.5 cells plated at a density of 6×10^5^ cells (6 cm dish), 6×10^4^ cells (12-well plate), 3×10^4^ cells (24-well plate), or 1×10^4^ cells (96-well plate), were infected with the virus suspended in DMEM (plus 10% FBS) at a multiplicity of infection (MOI) of 2. The virus was allowed to bind for 5--6 h at 37 °C in a 5% CO~2~ incubator, after which the inoculum was removed and the cells were replenished with fresh growth media without antibiotics and incubated further under the same conditions until harvest.

Virus titration {#s0080}
---------------

Virus infectivity was measured by indirect immunofluorescence analysis (IFA) as described ([@bib13]). Briefly, culture supernatants containing HCV were serially diluted 10-fold in complete DMEM and used to infect 1.9×10^5^ Huh7.5 cells seeded on glass coverslips in a 24-well plate. The inoculum was incubated with cells for 5 h at 37 °C and then replaced with fresh complete DMEM. IFA was performed at 24 h post-infection as described above using anti-NS5B antibodies generated in the lab and AlexaFluor 488 goat anti-mouse IgG antibody (Invitrogen).

Lentivirus was titrated using qPCR method as described ([@bib37]). Primer sequences were adapted from the same paper, WPRE for lentivirus-specific primers and albumin for host-specific gene and the corresponding TaqMan probes were synthesized by Integrated DNA Technology (IDT, Coralville, IA),. Briefly, culture supernatants containing lentivirus were serially diluted 10-fold in complete DMEM and used to transduce 1×10^5^ Huh7.5 cells seeded in 12-well plate in the presence of 10 μg/ml of polybrene. After 6 h, supernatant was replaced with fresh complete DMEM and cell genomic DNA was harvested at 72 h post-transduction using DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA) following the manufacturer's instruction. qPCR was performed as described ([@bib37]) and standard curve was generated using ten-fold serial dilutions of known concentration of plasmid constructs containing either WPRE or albumin sequences for quantification of unknown samples.

Small interfering RNA (siRNA)-mediated gene silencing {#s0085}
-----------------------------------------------------

A 21-nucleotide RNA duplex targeting the coding region of human BIK gene ([@bib27]) was purchased from Thermo Scientific Dharmacon (Dharmacon, Lafayette, CO). The siRNA sequences were as follows: 5′-GACCCCUCUCCAGAGACAUUU-3′ (sense) and 5′-AUGUCUCUGGAGAGGGGUCUU-3′ (antisense). The lyophilized siRNAs were reconstituted in RNase-free water to a final concentration of 20 μM. Control siRNA (an irrelevant siRNA targeting SARS-CoV polymerase) were transfected in parallel to serve as control. The siRNA transfection was performed using Lipofectamine RNAiMAX reagent (Invitrogen) according to the manufacturer's recommendations. Briefly, Huh7.5 cells were plated in antibiotic-free media at a density of 3×10^5^ cells and when 50% confluent, the cells were transfected with 20 nM of BIK siRNA or control siRNA. At 24 h post-transfection, the siRNA transfection media was removed and the cells were replenished with antibiotic-free media. Cells were harvested at 2, 4, 6, and 8 days post-transfection and the knockdown efficiency was examined by immunoblot analysis.

Isolation of total cellular RNA and reverse transcription {#s0090}
---------------------------------------------------------

Total RNA from Huh7.5 cells in 24-well plates infected with the J6/JFH1 virus or mock treated was isolated at 2, 4, and 6 days post- infection (d.p.i.). Following removal of culture medium, the cells were rinsed twice in PBS and RNA was extracted using an RNeasy Mini Kit with an on-column DNase treatment step (Qiagen) according to the manufacturer's protocol. Total RNA was reverse transcribed using the QuantiTect Reverse Transcription (RT) kit (Qiagen). For PCR array analysis, total RNA was reverse transcribed into cDNA using the RT^2^ First Strand Kit (SABiosciences, Frederick, MD) according to the manufacturer's instructions.

Gene expression profiling using PCR arrays {#s0095}
------------------------------------------

Template cDNA was mixed with RT^2^ SYBR Green/ROX qPCR master mix (SABiosciences) and 25 μl of this mixture was added to each well of the 96-well PCR array containing specific primer sets. The Human Apoptosis RT^2^ Profiler PCR Array (SABiosciences) examines 84 genes involved in the apoptotic pathway. These genes include members of the caspase, Bcl-2, IAP, TRAF, CARD, CIDE, death domain, death effector domain, and TNF receptor and ligand families, as well as genes involved in the p53 and DNA damage pathways. The array also contains primer sets for five housekeeping genes and three RNA and PCR quality controls. The PCR cycling program was performed using an ABI 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). Expression profiles of HCV-infected and mock-treated cells at the different time points were obtained from four independent experiments. The threshold cycle (*Ct*) values of each gene were used to calculate the fold changes in gene expression using the RT^2^ Profiler PCR Array Data Analysis software (<http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php>).

Quantitative real-time PCR {#s0100}
--------------------------

Gene expression changes observed with the PCR arrays were confirmed by quantitative real-time PCR using TaqMan chemistry. Probes and primers specific to the host genes that were identified by the PCR arrays to be up- or down-regulated in response to HCV infection were obtained from Applied Biosystems (Applied Biosystems). GAPDH was selected as the reference gene for normalization. Each reaction was performed in triplicates and no template controls were included for each primer/probe set. Amplification was monitored on an ABI 7900HT Fast Real-Time PCR System (Applied Biosystems). The difference in *Ct* values (Δ*Ct*) between the gene of interest and GAPDH control was used to calculate the fold changes in gene expression (2^−ΔΔ*Ct*^) between HCV-infected and mock-infected Huh7.5 cells. Results were pooled from at least three independent experiments.

Viral RNA quantification {#s0105}
------------------------

To measure the intracellular HCV RNA replication levels, cDNA was subjected to quantitative real-time PCR analysis using the SYBR Green-based detection system. The primer sequences are as follows: HCV primers (NS5A) 5′-AGA CGT ATT GAG GTC CAT GC-3′ (sense) 5′-CCG CAG CGA CGG TGC TGA TAG-3′ (antisense), GAPDH primers 5′-CAT GAG AAG TAT GAC AAC AGC CT-3′ (sense), 5′-AGT CCT TCC ACG ATA CCA AAG T-3′ (antisense). HCV and GAPDH transcript levels were determined relative to standard curves derived from serial dilutions of plasmids containing either the HCV J6/JFH-1 cDNA or the human GAPDH gene.

Lentivirus transduction {#s0110}
-----------------------

6×10^4^ of Huh7.5 cells were seeded in 12-well plate 24 h before transduction. Lentiviral particles packaging either the control vector or NS5B were used to transduce Huh7.5 cells at 0.1 TU/cell in the presence of 10 μg/ml of polybrene. Cells were harvested for RNA extraction and immunoblot analysis at 72 and 96 h post-transduction.

Cell viability assay {#s0115}
--------------------

The viability of the cells was determined using the CellTiter-Blue^®^ Cell Viability Assay (Promega, Madison, WI) which provides a homogeneous, fluorescent method for monitoring cell viability according to the manufacturer's instructions. Briefly, Huh7.5 cells were seeded in 96-well culture plates at a density of 1×10^4^ cells per well. After 24 h, the cells were infected with an appropriate MOI of HCV J6/JFH-1-P47. At specific time points post-infection, the CellTitre-Blue reagent was diluted (1:4) with PBS and added to each well, mixed for 2 min on an orbital shaker and incubated at 37 °C for 2 h. The fluorescence readings were measured at 570 nm using Tecan M200 microplate reader (Tecan Trading AG, Switzerland). Relative cell number was calculated by normalizing the absorbance to untreated cells. Relative cell viability was compared to untreated cells.

TUNEL assay {#s0120}
-----------

The Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was carried out using the DeadEnd Fluorometric TUNEL system (Promega) according to the manufacturer's protocol. Briefly, Huh7.5 cells were plated onto 4-well chamber slides (Lab-Tek™) at a density of 1×10^4^ cells per well, infected with HCV J6/JFH-1-P47. At the indicated time point post-infection, cells were fixed in 4% paraformaldehyde at 4 °C for 25 min. Fixed cells were then permeabilized in 0.1% Triton X-100 and labeled with fluorescein-12-dUTP using terminal deoxynucleotidyl transferase. After washing with 1X PBS, slides were mounted with VECTASHIELD^®^ mounting medium with DAPI (Vector Laboratories, Burlingame, CA). The TUNEL-positive cells (bright green spots) corresponding to the nuclei location (DAPI) were captured with Olympus FluoView FV1000 (Olympus, Japan) laser scanning confocal microscope using a 60×/1.45 oil objective, with 543 nm HeNe laser as the excitation source.

Caspase enzymatic activities {#s0125}
----------------------------

The activation of caspase-3/7, a hallmark of apoptosis, was measured using the Caspase-Glo 3/7 luminescent assay system (Promega) according to the manufacturer's instructions. An equal volume of Caspase-Glo reagent, which contains cell lysis buffer and luminogenic substrate containing the caspase-3 cleavage site tetrapeptide sequence DEVD, was added to cells cultured in an opaque 96-well microplate. The plate was incubated at room temperature for 2 h. Caspase cleavage of the substrate releases aminoluciferin and the amount of luminescence produced is proportional to the amount of caspase activity present in the sample. Luminescence was measured in relative light units (RLU) using a Tecan M200 microplate reader (Tecan).

Immunofluorescence assay (IFA) {#s0130}
------------------------------

For indirect immunofluorescence staining, transfected Huh 7.5 cells grown on coverslips were fixed with 4% paraformaldehyde for 15 min. Fixed cells were permeabilized with 0.1% Triton X-100 in PBS for 15 min, blocked with 1% bovine serum albumin (BSA) in PBS for 30 min and incubated with primary antibodies (ER-markers, anti-BIK, or anti-NS5B) for 1 h. For cells incubated with anti-BIK antibodies, after several washes, cells were first incubated with Alexa-Fluor-546-conjugated donkey anti-goat IgG for 1 h. After three 10 min washes with blocking buffer, cells were then incubated with Alexa-Fluor-488-conjugated goat anti-mouse IgG secondary antibodies or Alexa-Fluor-488-conjugated goat anti-rabbit IgG secondary antibodies (Invitrogen) for 1 h. The washed coverslips were then counter stained with 4′,6-diamidino-2-phenylindole (DAPI) and mounted on glass microscope slides using Fluorsave mounting medium (Calbiochem, Merck KGaA, Darmstadt, Germany). Images were captured with Olympus FluoView FV1000 (Olympus, Japan) laser scanning confocal microscope using 100× with 2× zoom oil objective, with 543 nm HeNe laser as the excitation source.

Co-immunoprecipitation (Co-IP) {#s0135}
------------------------------

Huh7.5 cells were infected with P47 virus at 2MOI. Cells were harvested at 2 d.p.i. and lysed using RIPA buffer (150 mM Tris--HCl, pH8.0, 250 mM NaCl, 0.5% NP40, 0.5% Sodium deoxycholate, 0.005% SDS). 100 µg of lysates were incubated with 1 µg of antibodies and 50 µl of Protein A agarose (Roche) at 4 °C on a nutator. After an overnight incubation, samples were washed at least 3 times with RIPA buffer at 3000 rpm, 4 °C. During the final wash, 15 µl of 2X SDS dye was added to the beads and samples were boiled at 100 °C for 15 min prior to analysis using SD-PAGE and Western blot.

Statistical analysis {#s0140}
--------------------

Statistical tests were mostly performed using Microsoft Excel and the RT2 Profiler PCR Array Data Analysis software in the case of PCR array data. All experiments were repeated at least three times. Statistical analysis was performed using the Student's *T*-test. *p*\<0.05 was considered significant. The relevant tests and level of significance are noted in the figure legends.

Appendix A. Supplementary materials {#s0150}
===================================

Supplementary data
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